Searched for
CHINA API SOURCING
Hari Menon exits BigBasket; Sarvam cofounder on fresh fundingBigBasket's longtime leader Hari Menon has stepped down as CEO. This and more in today's ETtech Top 5.- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Chinese AI models surge in 2026: Is JPMorgan data signaling a global shift away from US AI dominance?Chinese AI models are no longer just regional competitors. They are rapidly becoming a global artificial intelligence force. New JPMorgan d...
- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...
- Is Meta opening WhatsApp to rival AI chatbots just to avoid tougher EU action? Here's what happenedMeta has offered rival AI chatbots limited free access to WhatsApp in Europe, with charges to be implemented after a usage threshold is met...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Specialty chemicals: Is China still the same threat, or is this a contrarian moment? 7 stocks to be brought back on the watchlistWhen it comes to the Indian speciality chemicals sector, China and its dumping matters. But there have been subtle but significant changes ...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- India following diversified strategy to boost exports to China, cut import dependence: OfficialIndia is pursuing a multi-pronged approach to boost its exports to China. The nation is focusing on building its own industrial capabilitie...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Rising costs of key chemicals choke production at drug ingredient makersIndia's bulk-drug manufacturers are facing a severe cost crisis as prices of key solvents and intermediates have surged due to supply disru...
- API prices fall sharply, easing pressure on India's pharmaceutical industryIndia's pharmaceutical industry is experiencing relief as active pharmaceutical ingredient (API) prices plummet due to overcapacity and agg...
- India urges China to stabilise price of APIs linked to Covid-19Indian pharmaceutical companies source almost 70% of their requirement of Covid-19-related APIs from China. Demand for Covid-19-related med...
- India needs holistic ecosystem to rebuild API manufacturing facilities: PwC IndiaThe study recommended that to revive the API industry, in the immediate term there is a need for faster environment clearance, encouraging ...
- Government to curb pharma imports from ChinaHigher duties on Chinese products may also be on the cards, official sources said. These moves gathered pace in the wake of the military fa...
- Icra revises domestic pharma industry outlook to negative due to coronavirus outbreakIt has revised its outlook due to ongoing lockouts in China following the outbreak of coronavirus.
- DCGI mulls alternatives to China active pharmaceutical ingredientsThe Indian Drug Manufacturers Association (IDMA), a lobby group of domestic pharma firms, recently submitted a six-page action plan.
- Drug prices may rise as China cuts sopsChina’s recent slashing of export incentives for reducing its trade surplus, has sent Indian pharma manufacturers in a tizzy, with some man...
- Indian pharmas increase API imports from ChinaEven as Indian active pharmaceutical ingredients (API) makers compete with Chinese companies globally, growing API imports from China to In...
Load More
